KenChowder
I only have one more post for the say so I will
KenChowder
I only have one more post for the say so I will try to address both of your points - from my perspective. My perspective if from having worked more than 25 years in the pharma Industry including at Pfizer when they bought our company. Also please realize that I have too many shares of CYDY and think the price should be much higher which is why I am holding and telling those I convince to buy the stock to do the same.
We are too focused on these message boards about conspiracy theories - that the company leaders don’t support.
The facts are that our clinical trials did not yield results that justify full approval. I was hopeful that EUA with a commitment to complete a trial in x period of time would be granted but it was not. We can’t complain about the poor approval process for REM, HYDROXY, and plasma and them jump and down and say the fda should do the same thing for CYDY. With the same data for months no other FIRST world regulatory body has approved this either for COVID or HIV. This should tell us all something as these countries have the same or worse situation vs. the US.
As far as Pfizer actively blocking this to allow us to get booster shots that is a stretch as well. I would not hesitate to get a booster shot when it is available because I want to prevent getting COVID and then progressing to severe and hoping that I am one of the people LL saved and Pfizer’s marketing team will likely view the competition to be Moderna and not CYDY.
I am hopeful but realistic about our chances for EUA in the US - which I view as extremely low with the current data.
If a congressional subcommittee where to investigate this situation they would depose the CEO who would likely say there was no issue - investigation closed.
I have been thinking that every quarter since 2017 would be the golden quarter and we have heard so many forward looking statements on the HIV BLA that CYDY had all we needed to answer the open questions that we had a real good understanding of. We are more than a year after the RTF and we are hopefully going to submit the CMC section in June - the big problem was the clinical section and they keep sidestepping the question on when that will finally be ready.
I have been quiet lately but am really frustrated and mad that we precipitated the 30% decline in stock price due to the fda feeling they had to respond to all the pestering
LL still binds to CCR5 and is safe so I still expect us to have our day in the US but we need to challenge our CYDY team to get us there and not fight the FDA.
All IMO
12
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...
Continue Reading
Profit and loss dance around like a jittery stock, and Dawson Geophysical is feeling the heat this third quarter. Numbers are in, and we’re seeing a net loss of $5.2 million, translating to $0.17 per share—ouch. Not to mention a negative Adjusted EBITDA of $2 million. Compared to last year's hopes, that's a serious belly flop. Revenue Down, Hopes Up In a fetching...
Continue Reading
Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...
Continue Reading
Plugging Into the Future of Travel ELEGRP's latest move brings the Dyson Supersonic Travel hair dryer into the limelight, all decked out with global voltage compatibility. It's like the Swiss Army knife of hair dryers—one minute it’s working on 100V, next it’s flipping over to a juicy 240V, without breaking a sweat. The ALCI Difference: Safety Takes Center Stage...
Continue Reading
A Blitz of Wires and Innovation Boy, did Phoenix Contact shake things up in Blomberg. On a crisp November day, a group of fresh-faced first-year students pulled off something astounding—wiring 500 terminal blocks in a jaw-dropping 2 minutes and 20 seconds. This wasn’t just any effort; it was enough to earn them a shiny new Guinness World Record. What they did wasn’t...
Continue Reading
Forecasts on Market Growth: A Robust Climb Ahead Brace yourself because this mining equipment racket is ramping up like you wouldn't believe. Analysts are telling us the market's supposed to roar from a $28.42 billion check in 2026 to a jaw-dropping $42.81 billion come 2033. That's a 6.0% CAGR—a figure that'll catch the eye of anyone not sound asleep at the wheel....
Continue Reading
New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...
Continue Reading
SANY's Future Vision: AI Agents and Robotic Machinery The construction machinery game is about to get a whole lot smarter, if SANY has anything to say about it. They're rolling out their biggest show ever at bauma CHINA 2026, and the headline act? A fresh breed of AI agents and robotic machinery that promises to revolutionize the industry. Marking its 40-year legacy, SANY...
Continue Reading
A New Feather in RBC's Cap RBC Wealth Management has racked up more accolades, crowned as the Best Private Bank in Canada and celebrated for its prowess in impact and sustainable investing on the global stage. These distinctions flew in courtesy of the PWM Global Private Banking Awards—a heavyweight recognition in the wealth management world. Award Winning Strategy in...
Continue Reading
Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...
Continue Reading
Top 5 Most Recently Viewed Articles
Apirone's Transformative Year: Innovations and Achievements As we reflect on the recent progress made by Apirone, a leading cryptocurrency services provider, it is clear that 2025 marked a groundbreaking year in the company’s evolution. With a steadfast commitment to fostering innovation and enhancing user engagement, Apirone has undertaken a series of pivotal...
Continue Reading
Green Rain Energy Takes Strategic Steps to Strengthen Capital Structure Green Rain Energy Holdings Inc. (OTCID: GREH) has made an announcement that reflects its commitment to enhancing shareholder value and addressing market dynamics. The Chief Executive Officer, Alfredo Papadakis, plans to cancel 310 million common shares held through a holding company. This bold move...
Continue Reading
Positive Insights from Piper Sandler on Webster Financial Piper Sandler has reaffirmed its Overweight rating on Webster Financial Corporation (NYSE: WBS), setting a steadfast price target of $54.00. This rating reflects confidence in the bank's potential for recovery and growth, despite recent challenges faced by the company. Current Performance Analysis Despite a...
Continue Reading
City Furniture Celebrates Exciting Grand Opening CITY Furniture, a leading home furnishings retailer, has celebrated the successful grand opening of its expansive 120,000-square-foot showroom in Sarasota. This event not only marks a significant milestone in the company's growth but also embodies its commitment to transforming the home shopping experience in the Tampa...
Continue Reading
Scott Alexander Rose Recognized as a Pinnacle Achiever 2024 Scott Alexander Rose has been prominently featured and acknowledged as a Pinnacle Achiever 2024 for his exemplary contributions to education and philanthropy. His dedication reflects a lifetime of service and commitment to making a meaningful impact. A Commitment to Education and Excellence Dr. Rose's academic...
Continue Reading